Cargando…
Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer
BACKGROUND: The goal of therapy for many patients with advanced stage malignancies, including those with metastatic gastric and esophageal cancers, is to extend overall survival while also maintaining quality of life. After weighing the risks and benefits of treatment with palliative chemotherapy (P...
Autores principales: | Ma, Xiaoyuan, Pierce, Eric, Anand, Harsh, Aviles, Natalie, Kunk, Paul, Alemazkoor, Negin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536729/ https://www.ncbi.nlm.nih.gov/pubmed/37759332 http://dx.doi.org/10.1186/s12885-023-11422-z |
Ejemplares similares
-
Analysis of Prognostic Factors and Design of Prognosis Model for Patients with Stage IV Gastric Cancer Following First-Line Palliative Chemotherapy
por: Zhou, Qiyin, et al.
Publicado: (2020) -
Perioperative and Palliative Chemotherapy for Esophageal Cancer
por: Behrens, Angelika, et al.
Publicado: (2015) -
Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy
por: Kim, Jeong Eun, et al.
Publicado: (2023) -
Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
por: Shi, Tao, et al.
Publicado: (2019) -
Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy
por: Cameron, Silke, et al.
Publicado: (2009)